Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)–nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction
- 1.8k Downloads
Insulin effects reportedly involve reactive oxygen species (ROS) and oxidative stress in vitro, but skeletal muscle oxidative stress is an emerging negative regulator of insulin action following high-fat feeding. NEFA may enhance oxidative stress and insulin resistance. We investigated the acute impact of insulin with or without NEFA elevation on muscle ROS generation and insulin signalling, and the potential association with altered muscle mitochondrial function.
We used hyperinsulinaemic–euglycaemic clamping, 150 min, without or with lipid infusion to modulate plasma NEFA concentration in lean rats.
Insulin and glucose (Ins) infusion selectively enhanced xanthine oxidase-dependent muscle ROS generation. Ins with lipid infusion (Ins+NEFA) lowered whole-body glucose disposal and muscle insulin signalling, and these effects were associated with high muscle mitochondrial ROS generation and activation of the proinflammatory nuclear factor-κB inhibitor (IκB)–nuclear factor-κB (NFκB) pathway. Antioxidant infusion prevented NEFA-induced systemic insulin resistance and changes in muscle mitochondrial ROS generation, IκB-NFκB pathway and insulin signalling. Changes in insulin sensitivity and signalling were independent of changes in mitochondrial enzyme activity and ATP production, which, in turn, were not impaired by changes in ROS generation under any condition.
Acute muscle insulin effects include enhanced ROS generation through xanthine oxidase. Additional NEFA elevation enhances mitochondrial ROS generation, activates IκB–NFκB and reduces insulin signalling. These alterations are not associated with acute reductions in mitochondrial enzyme activity and ATP production, and are reversed by antioxidant infusion. Thus, NEFA acutely cause systemic and muscle insulin resistance by enhancing muscle oxidative stress through mitochondrial ROS generation and IκB–NFκB activation.
KeywordsFatty acids Inflammation Insulin Insulin resistance Mitochondria Oxidative stress
V-akt murine thymoma viral oncogene homologue 1
Carbonyl cyanide m-chlorophenyl hydrazone
8 mmol/l glutamate, 4 mmol/l malate
4 mmol/l glutamate, 8 mmol/l succinate
4 mmol/l glutamate, 2 mmol/l malate, 10 mmol/l succinate
Nuclear factor-κB inhibitor (α)
Insulin and glucose [infusion]
50 μmol/l palmitoyl-l-carnitine, 2 mmol/l malate
5 mmol/l pyruvate, 5 mmol/l malate
0.25 mmol/l pyruvate, 12.5 μmol/l palmitoyl-l-carnitine, 2.5 mmol/l α-ketoglutarate, 0.25 mmol/l malate
Reactive oxygen species
10 mmol/l succinate
20 mmol/l succinate, 0.1 mmol/l rotenone
Insulin has been shown to enhance reactive oxygen species (ROS) generation and oxidative stress in adipose and liver cells in vitro, and these effects are reported to be directly involved in the stimulation of insulin signalling by inactivation of protein phosphatases [1, 2, 3]. A more recent study also found that mice lacking the major antioxidant enzyme glutathione peroxidase have high muscle oxidative stress and are less, rather than more, insulin resistant than wild-type counterparts . In contrast with the above observations, oxidative stress markers are elevated in insulin-resistant obese and type 2 diabetic individuals [3, 5, 6], and oxidative stress is reported to occur in, and directly contribute to, fat-induced insulin resistance in skeletal muscle in high-fat-fed rodents . Available data also indicate that oxidative-stress-induced insulin resistance involves nuclear factor-κB (NFκB) nuclear translocation after nuclear factor-κB inhibitor α (IκBα) phosphorylation and degradation . The potential involvement of chronic NEFA elevation in high-fat-diet-induced changes in muscle oxidative stress, inflammation and insulin action is suggested by in vitro studies [9, 10], and fatty acids are also reported to induce insulin resistance in vivo [11, 12]. In addition, the onset of oxidative stress and inflammation during chronic high-fat or high-energy feeding has been reported to lower skeletal muscle mitochondrial oxidative capacity [13, 14], and this alteration could contribute to insulin resistance through impaired muscle lipid oxidation . The in vivo effects of NEFA on muscle oxidative stress, inflammation and mitochondrial function as well as the potential pathways involved and their associations with insulin signalling remain, however, undefined.
In the current study we sought to determine the potential interactions between insulin and NEFA in the regulation of muscle ROS generation and insulin sensitivity in vivo. The impact of physiological insulin elevation on muscle ROS generation from different mitochondrial and non-mitochondrial sources was investigated using the hyperinsulinaemic–euglycaemic clamp technique. The potential additional impact of concomitant NEFA elevation on muscle ROS generation, the ROS-activated IκB–NFκB proinflammatory pathway and insulin action was also investigated in the presence and absence of antioxidants. Parallel changes in muscle mitochondrial function were determined in order to assess their response to acute changes in tissue redox state and their potential association with changes in insulin sensitivity.
Animals and experimental protocol
The experimental protocol was approved by the Committee for Animal Studies at Trieste University. Seventy 12-week-old male Wistar rats were purchased from Harlan-Italy (San Pietro al Natisone, Udine, Italy) and kept for 2 weeks in the Animal Facility of the University of Trieste in individual cages with a 12 h light–dark cycle (06:00 hours/18:00 hours). Starting 3 days before the experiments, 4 h tail-restraint periods were performed each day  by pulling the tail through a tail-sized hole in the cage and securing it to a horizontal Plexiglass support. Animals had free access to water and standard rat chow (Harlan 2018, 14.2 kJ/g, Harlan, San Pietro al Natisone, Italy). To minimise potential stress responses and eliminate any differential response among groups, identical restraining training and study protocols were applied to all animal groups. No significant changes in blood glucose, a relevant stress marker, were observed following the 4 h adaptation periods (data not shown).
On the morning of the infusion day, catheters were placed percutaneously into one tail vein and one tail artery under local lidocaine anaesthesia , and the tail was then secured as described above. Food was withdrawn after catheter placement and animals were kept in this position for 4 h before the infusions were started. Immediately before the start of infusions (t = 0), 250 μl blood samples were drawn from the artery for basal measurements of blood glucose (Accu-Chek, Roche Diagnostic Corporation, Indianapolis, IN, USA) or stored at −80°C for measurement of insulin and NEFA. Rats were randomly assigned to undergo one of the following 150 min infusion protocols: (1) control, NaCl infusion (n = 18); (2) insulin and glucose (Ins), hyperinsulinaemic–euglycaemic clamp with insulin infusion (Humulin R; Eli Lilly, Indianapolis IN, USA) at 5 mU kg−1 min−1 and variable 20% glucose to maintain near-basal blood glucose concentration (n = 20); (3) Ins and lipid (Ins+NEFA), as above with additional infusions of a lipid emulsion (Ivelip 20%, Clintec Parenteral, Maurepas, France) at 600 μl/h and heparin (20 U/h; Epsoclar, Biologici Italia, Novate Milanese, Italia) aimed at elevating circulating NEFA (n = 20); (4) Ins+NEFA and N-acetyl cysteine (NAC; Ins+NEFA+NAC), as described above but with the addition of NAC (Sigma, St Louis MO, USA) (n = 10). An initial priming dose (75 mg/kg) was injected in the tail artery 20 min before the infusion, and continuous (25 mg kg−1 h−1) i.v. infusion was performed during the euglycaemic clamp. Selection of NAC dose and delivery was based on literature review . Heparin infusion identical to that in the Ins+NEFA group was performed in both other experimental groups. In all animals, blood glucose was monitored every 15 min, and glucose infusion rates were adjusted accordingly in the Ins and Ins+NEFA groups to maintain near-basal levels. At 60 and 120 min, 100 μl blood samples were taken to measure intermediate levels of plasma insulin and NEFA. At 150 min, 250 μl blood samples were again taken for measurement of final variables. Adequate anaesthesia was then induced by pentobarbital (40 mg/kg, i.v.) and gastrocnemius muscle was isolated by surgical dissection. Muscle was quickly removed and an aliquot placed in ice-cold NaCl 0.9% (wt/vol.) for immediate transfer and analysis. The rest of the tissue was immediately frozen in liquid nitrogen and stored at −80°C.
Mitochondrial H2O2 production
ROS production in intact isolated mitochondria was measured by adapting previously described protocols . A sample of fresh tissue was cleaned of connective tissue, placed in buffer SH (10.5 mmol/l HEPES, pH = 7.2, 250 mmol/l sucrose, 1 mmol/l EGTA, 0.5% [wt/vol.] BSA) and homogenised in ice. Mitochondria were then isolated by differential centrifugation: myofibrillar fraction was removed (720 g, 4°C, 5 min), and mitochondria were pelleted (10,000 g, 4°C, 5 min), washed in buffer SH and resuspended in buffer R (20 mmol/l HEPES, pH = 7.2, 4 mmol/l KH2PO4, 1 mmol/l MgCl2, 14 mmol/l NaCl, 125 mmol/l KCl, 20 μmol/l EGTA). An aliquot of the resuspended fraction was frozen at −80°C for measurement of protein content (BCA assay, Pierce, Rockford IL, USA). Concentrated respiratory inhibitors and substrates had been prepared previously, aliquoted and stored at −80°C. Working dilutions were prepared immediately before use. The final concentrations in the assay were: carbonyl cyanide m-chlorophenyl hydrazone (CCCP; 5 μmol/l); antimycin A (AA; 1 μg/ml); 5 mmol/l pyruvate, 5 mmol/l malate (PM); 8 mmol/l glutamate, 4 mmol/l malate (GM); 10 mmol/l succinate (S); 4 mmol/l glutamate, 2 mmol/l malate, 10 mmol/l succinate (GMS); 50 μmol/l palmitoyl-l-carnitine, 2 mmol/l malate (PCM); 4 mmol/l glutamate, 8 mmol/l succinate (GS).
The rate of H2O2 synthesis in freshly isolated mitochondria was measured by monitoring the conversion of Amplex Red (Invitrogen, Carlsbad, CA, USA) to resorufin using a microplate fluorimeter (Infinite F200, Tecan Group, Switzerland; excitation 535 nm, emission 595 nm, 25 flashes, integration time 20 μs). Freshly prepared mitochondrial suspension, 20 μl, was added to a 96 well microplate (Nunc, Rockford, IL, USA). Wells in each row contained 200 μl assay buffer (10 μmol/l Amplex Red, 0.4 U/ml horseradish peroxidase [HRP], 0.2% [wt/vol.] BSA in buffer R) and 20 μl of ultrapure H2O, respiration uncoupler (CCCP) or inhibitor (AA). The microplate was incubated for 20 min at 37°C. State 4 mitochondrial respiration H2O2 production was measured after addition, for each row, of 20 μl of either ultrapure H2O or respiration substrate. Integrity of mitochondrial function was determined by measuring the effects of CCCP and AA, as well as the decrease in H2O2 synthesis with a third incubation after the addition of 1 mmol/l ADP in each well (state 3 respiration). The rate of H2O2 synthesis was calculated by interpolation of resorufin fluorescence variation over time with a calibration curve from H2O2 standards (3 μmol/l to 20 nmol/l). Data were normalised by sample protein content and expressed as pmol (mg protein)−1 min−1.
Superoxide anion generation
Cellular superoxide anion production systems in gastrocnemius lateralis muscle homogenate were assayed combining specific substrates and inhibitors for each source. Detection was performed using the lucigenin chemiluminescence method . Lucigenin concentration in the assay was 10 μmol/l to prevent redox cycling. Briefly, freshly isolated tissue was cleaned of connective tissue and homogenised in ice-cold Krebs–HEPES buffer (20 mmol/l HEPES, pH = 7.4, 99 mmol/l NaCl, 4.7 mmol/l KCl, 1.2 mmol/l MgSO4, 1 mmol/l KH2PO4, 1.9 mmol/l CaCl2, 25 mmol/l NaHCO3, 11 mmol/l d-glucose) with protease inhibitors (Sigma). After centrifugation to remove insoluble debris (240×g, 15 min, 4°C), the suspension was diluted in Krebs–HEPES buffer and lucigenin was added. An 180 μl volume of the mixture was rapidly transferred to a white 96-well microplate (Nunc). Each well already contained 20 μl of either ultrapure H2O for sample basal superoxide measurement or the superoxide scavenger tiron (10 mmol/l) as a negative control and, to test single sources: xanthine (500 μmol/l) with or without the inhibitor oxypurinol (200 μmol/l); NADPH (1 mmol/l) with or without the inhibitor diphenyleneiodonium (200 μmol/l); the cyclo-oxygenase inhibitor indometacin (100 μmol/l); or the mitochondrial uncoupler CCCP (5 μmol/l). In pilot experiments the concentrations for all substrates and inhibitors were tested, and did not alter luminescence in the absence of cellular homogenate. During incubation at 37°C, from 10 to 30 min, light emission was monitored every 6 s in a microplate luminometer (Sinergy2, BioTek Instruments, Winooski, VT, USA). To ensure all measurements related to superoxide production, a subsequent reading was performed after addition of tiron to all wells. Samples were run in duplicate. The results were calculated for each well by integration of single light-emission measurements and normalised by protein content in the sample (BCA assay, Pierce). For each source, relative superoxide production was assumed as the difference between basal or, when available, substrate-stimulated production values and the values obtained with the addition of the specific inhibitor.
Glutathione is the major buffering system for scavenging ROS, and a shift towards its oxidised form reflects a more oxidised tissue redox state . Total and oxidised glutathione (GSSG) levels were determined in tissue homogenates using the HT Glutathione Assay Kit (Trevigen, Gaithersburg, MD, USA). Briefly, ~50 mg of the gastrocnemius sample was cleaned and homogenised in ice-cold 5% (wt/vol.) metaphosphoric acid (20 ml/g tissue). Homogenates were then centrifuged (12,000×g for 15 min) and the supernatant fraction was used for total glutathione measurement after appropriate dilution. For oxidised glutathione, samples were pretreated with 2 mol/l 4-vinylpyridine. Total and GSSG were then measured using the reagents and calibration set provided by the HT Glutathione Assay Kit. Reduced glutathione (GSH) was calculated by subtracting the oxidised fraction from the total.
Total tissue protein was extracted from homogenised tissue as described . Protein concentrations in all samples were measured by spectrophotometer (BCA Protein Assay Reagent, Pierce, Rockford, IL, USA). Total v-akt murine thymoma viral oncogene homologue 1 (AKT), phospho(Ser473)-AKT, total IκBα and phospho(Ser32)-IκBα were measured by western blotting using commercially available antibodies (Cell Signaling Technology, Beverly, MA, USA) . Individual results were expressed as percentages of the average values in the control group.
Electrophoretic mobility shift assay
Nuclei from rat muscle were prepared with a modified version of previously described methods . Tissue samples were homogenised in a buffered sucrose–salt solution (0.2 mmol/l K2HPO4, 0.6 mmol/l KH2PO4, 0.32 mol/l sucrose, 1 mmol/l MgCl2, pH = 6.8) with protease inhibitors (Sigma), nuclei were collected by centrifugation (800×g, 5 min, 4°C) and washed with the same procedure. Myofibrils and mitochondria were removed by prolonged high-speed centrifugation (16,000×g, 90 min, 4°C) after resuspension in high-sucrose buffer (0.2 mmol/l K2HPO4, 0.6 mmol/l KH2PO4, 2.15 mol/l sucrose, 1 mmol/l MgCl2, pH = 6.8). Isolated nuclei were resuspended in PBS, pH = 7.4. Protein content was measured by standard BCA assay (Pierce). Complementary 3′-biotinylated synthetic oligonucleotides containing a high-affinity consensus sequence for NFκB (forward: 5′-AGTTGAGGGGACTTTCCCAGGC-3′-biotin) were annealed by dilution (50 mmol/l Tris, pH 8.0, 100 mmol/l NaCl), heating to 95°C for 4 min and subsequent thermal downramping (0.5°C/min) to 20°C in a thermocycler (MyCycler, Bio-Rad, Hercules, CA, USA). Incubation for the binding reaction was performed at room temperature for 30 min, after mixing in a reaction volume of 10 μl, binding buffer (final concentrations: 10 mmol/l Tris, pH = 8.0, 50 mmol/l NaCl, 1 mmol/l EDTA, 1 mmol/l dithiothreitol, 0.05% [wt/vol.] BSA, 0.05% [wt/vol.] NP-40, 5% [wt/vol.] glycerol), 1.5 pmol probe and 50 μg of each nuclear protein extract. Polydeoxyinosinic-deoxycytidylic acid (0.05 μg/μl) was added for non-specific competition. As a control for the specificity of the bands some samples were incubated in competition with 100-fold concentration of non-biotinylated probe. Samples were then loaded and run on a continuous 5% PAGE at 100 V and transferred to nylon membrane (Hybond N+, GE Healthcare, Chalfont St Giles, UK) for 2 h at 380 mA. Both electrophoreses were performed in refrigerated ×0.5 TE buffer (45 mmol/l Tris, 45 mmol/l boric acid, 1 mmol/l EDTA). Oligomers were cross-linked to the membrane by UV exposure (UVC500, Hoefer, Holliston, MA, USA). After blocking (10 mmol/l PBS, pH = 7.4, 150 mmol/l NaCl, 0.5% [wt/vol.] casein, 0.2% [wt/vol.] SDS) for 1 h at 37°C under gentle shaking, and washing (10 mmol/l PBS, pH = 7.4, 0.1% [wt/vol.] Tween-20), biotin recognition on the membrane was performed by incubation for 30 min with streptavidin–HRP conjugate (Sigma) in detection buffer (10 mmol/l PBS, pH = 7.4, 0.1% [wt/vol.] Casein, 0.1% [wt/vol.] Tween-20). Following extensive washing and enhanced chemiluminescence (LumiGLO, Cell Signaling, Beverly, MA, USA), membranes were exposed and densitometric analysis was performed.
Cytochrome c oxidase and citrate synthase activities
Cytochrome c oxidase and citrate synthase enzyme activities were measured spectrophotometrically from tissue homogenates as described previously .
ATP synthesis rate was measured on freshly isolated mitochondria as described , with slight modifications. Mitochondria were isolated by differential centrifugation as described for the mitochondrial ROS assay, except that buffers A (50 mmol/l Tris, pH 7.2, 100 mmol/l KCl, 5 mmol/l MgCl2, 1.8 mmol/l ATP, 1 mmol/l EDTA) and B (225 mmol/l sucrose, 44 mmol/l KH2PO4, 12.5 mmol/l Mg(CH3COO)2, 6 mmol/l EDTA) were used in place of SH and R. The efficiency of purification and mitochondrial integrity were confirmed by citrate synthase assays on isolation fractions. Concentrated respiration substrates had been prepared previously, aliquoted and frozen at −80°C. Their composition and final reaction concentrations were: 0.25 mmol/l pyruvate, 12.5 μmol/l palmitoyl-l-carnitine, 2.5 mmol/l α-ketoglutarate, 0.25 mmol/l malate (PPKM); 25 μmol/l palmitoyl-l-carnitine, 0.5 mmol/l malate (PCM); 20 mmol/l succinate, 0.1 mmol/l rotenone (SR); and 10 mmol/l glutamate, 5 mmol/l malate (GM). The ATP synthesis rate was assayed by kinetic measurement of light emission from each well (interval 2 min, integration time 1 s) using a microplate luminometer (Synergy 2 SL, BioTek). Each well contained 25 μl of diluted sample or ATP standard (50–0 μmol/l) in buffer B, 25 μl of substrate (PCM, PPKM, SR or GM) and 175 μl of assay buffer containing luciferin and luciferase (ATP Reagent SL; BioThema, Handen, Sweden). Finally, 25 μl of ADP l mmol/l, previously cleared from ATP contamination by glucose/hexokinase incubation, were added in each well to start state 3 respiration. All samples were run in duplicate. 250 μg of oligomycin was added to some wells to verify that ATP was generated from mitochondrial respiration. The luciferase-related ATP decrease rate was calculated from standards and used to correct measurement slopes. ATP synthesis rate was then calculated by interpolation of the light emission per min in the linear phase with the ATP standard curve. Measurements obtained were normalised by protein concentration in the mitochondrial fraction preparation, as measured by BCA protein assay (Pierce) and expressed as μmol (mg protein)−1 min−1.
Plasma insulin and NEFA
Plasma insulin concentration was measured by radioimmunoassay using a commercially available kit (Linco, St Louis, MO, USA). Plasma NEFA were determined spectrophotometrically (NEFA-C; WAKO Pure Chemical Industries, Osaka, Japan).
Results in the four groups were compared using one-way ANOVA. Post hoc tests were then used to compare the results of two groups. The paired Student’s t test was used to compare results before and following infusions. A p value of <0.05 was considered statistically significant.
Body weight and plasma metabolic profile
Insulin-mediated glucose disposal and skeletal muscle insulin signalling
Skeletal muscle mitochondrial ROS generation, superoxide production and GSSG-GSH levels
IκBα subunit and NFκB–DNA interaction
Mitochondrial enzyme activities and ATP production
The major findings of this study are that: (1) hyperinsulinaemia in the high physiological range causes a shift towards a more oxidised redox state in rat skeletal muscle in vivo, selectively associated with enhanced ROS production at the xanthine oxidase level; (2) concomitant NEFA elevation lowers insulin action, in association with enhanced muscle ROS production at the mitochondrial level and IκB-NFκB activation; (3) NEFA-induced metabolic alterations are prevented by antioxidant infusion and are therefore caused by their mitochondrial pro-oxidant effects with IκB–NFκB involvement; (4) acute changes in muscle mitochondrial ROS production, redox state and insulin signalling are not associated with impaired tissue mitochondrial function under the current experimental conditions.
The current study introduces the concept that pro-oxidative modulation of the muscle redox state is a physiological effect of insulin in vivo. Insulin had been reported to enhance the generation of ROS in adipose and liver cells in vitro [1, 2], with involvement of NADPH oxidase and no negative impact on insulin signalling [1, 2]. The current data show that pro-oxidant insulin-induced changes in superoxide production and redox state are, however, not associated with proinflammatory changes in skeletal muscle of lean animals in the absence of concomitant NEFA elevation. These findings are therefore consistent with previous reports indicating that insulin-induced oxidative stress per se has no major negative metabolic effects and does not activate major insulin-desensitising metabolic pathways in non-muscle tissues [1, 2, 3, 4]. Under the current conditions, the data also identify xanthine oxidase as a selective non-mitochondrial source mediating insulin-induced superoxide production, and this finding is intriguing as it introduces a novel link between insulin, oxidative stress and the xanthine oxidase pathway. Additional studies should be specifically designed to investigate potential interactions between insulin, xanthine oxidase and insulin signalling in models of chronic oxidative stress characterised by insulin resistance and hyperinsulinaemia.
Fatty acid elevation profoundly modulated muscle insulin effects, leading to lower insulin signalling activation associated with selective enhancement of mitochondrial ROS production, pro-oxidative changes in tissue redox state and activation of the IκB–NFκB proinflammatory pathway. The different metabolic impact of quantitatively different levels of ROS production, such as those observed during insulin infusion with and without NEFA, is consistent with previously reported differential effects of low and high levels of ROS on key physiological muscle functions, such as contractile strength and sarcoplasmic reticulum calcium release . In addition, the possibility that different sites and pathways of ROS production have different effects on muscle metabolic pathways cannot be excluded. Overall, the data identify a novel cluster of NEFA-induced muscle metabolic alterations in the presence of physiological hyperinsulinaemia. Also importantly, concomitant infusion of the antioxidant ROS scavenger NAC prevented the above changes. This observation provides direct evidence for a causal role of mitochondrial ROS production and oxidative stress in the onset of fatty-acid-induced muscle insulin resistance with involvement of the IκB–NFκB pathway, the activation of which by ROS has been previously reported under different experimental conditions .
It should be pointed out that the current experiments were designed to investigate insulin–fatty acid interactions, and the observed metabolic effects cannot be assumed to extend to conditions of isolated fatty acid elevation. Independent effects of fatty acids on muscle redox state are, however, also supported by in vitro studies [9, 10]. Moreover, the current conditions have direct pathophysiological implications in the postprandial state, when hyperinsulinaemia is associated with variable changes in plasma NEFA concentration depending on meal composition [7, 25]. Fatty acid elevation in our study is indeed comparable with reported peak fatty acid increments following fatty meals in humans , suggesting that elevated fatty acid availability following ingestion of a fatty meal may directly cause muscle oxidative stress and inflammation, leading to acute insulin resistance. Importantly, less pronounced elevations of plasma insulin and NEFA concentrations are also observed in obesity induced by long-term high-fat feeding. A contribution of fatty acids to oxidative stress and inflammation previously reported under the above conditions is suggested by the current results [7, 13, 14], but the direct investigation of this will require further studies with less pronounced and more sustained fatty acid elevation.
Although the issue is partly controversial, chronic changes in mitochondrial oxidative capacity and function have been proposed to contribute to modulation of muscle insulin action by regulating lipid oxidative use [15, 26]. Oxidative stress and proinflammatory cytokines were also reported to lower markers of muscle mitochondrial content and function in the context of chronic high-fat feeding [13, 14]. The current study, however, demonstrated that acute peak physiological fatty acid elevation does not impair mitochondrial enzyme activities or ATP production, which can instead be enhanced by higher lipid substrate availability even in the presence of enhanced ROS production. While this last finding is consistent with a recent study showing that high ROS production in ageing human skeletal muscle is not associated with impaired mitochondrial respiration , the current results support the view that the onset of insulin resistance is, at least in part, independent of the inhibition of mitochondrial enzyme activities and ATP production capacity .
In summary, the current findings demonstrate that acute insulin elevation in the physiological range induces pro-oxidative changes in muscle redox state through the non-mitochondrial xanthine oxidase pathway. This novel insulin effect does not, however, appear to lead to major negative metabolic effects in the absence of simultaneous NEFA elevation. On the other hand, further enhancement of ROS production at the mitochondrial level by fatty acid infusion causes muscle and systemic insulin resistance through activation of the IκB–NFκB pathway. These changes could play a key role in the negative impact of NEFA on insulin action following fat ingestion, and potentially in the onset of obesity-associated metabolic alterations. Acute changes in muscle mitochondrial ROS production, redox state and insulin signalling are not associated with impaired tissue mitochondrial function under the current experimental conditions.
The study was supported in part by a fellowship to R. Barazzoni from the European Society for Clinical Nutrition and Metabolism (ESPEN). The authors gratefully acknowledge the skilful assistance of G. Cadelli, M. Stebel and P. Zarattini (Animal Facility, University of Trieste) in rat vein and artery cannulation, and of M. de Nardo and L. Mamolo (Clinica Medica, Department of Medical, Surgical and Health Sciences) in performing infusion experiments. Assistance from G. Lunazzi (Clinica Medica, Department of Medical, Surgical and Health Sciences) in performing some western blotting experiments is also acknowledged.
RB was involved in the conception and design of the study, data interpretation and drafting and revision of the article; MZ contributed to data interpretation and revision of the article; GGC was involved in data analysis and interpretation and revision of the article; AS contributed to data analysis and interpretation, and revision of the article; MB was involved in data analysis, and revision of the article; EC was involved in data analysis, and revision of the article; AP contributed to data analysis, and revision of the article; LC was involved in data analysis and revision of the article; GG contributed to interpretation of data, revising the article. All authors approved the final version to be published.
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.
- 22.Barazzoni R, Zanetti M, Bosutti A et al (2005) Moderate caloric restriction, but not physiological hyperleptinemia per se, enhances mitochondrial oxidative capacity in rat liver and skeletal muscle—tissue-specific impact on tissue triglyceride content and AKT activation. Endocrinology 146:2098–2106PubMedCrossRefGoogle Scholar
- 27.Lefort N, Glancy B, Bowen B et al (2010) Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 59:2444–2452PubMedCrossRefGoogle Scholar